Class Action Lawsuit Filed Alleging Azor Causes Serious Gastrointestinal Problems
Plaintiff alleges Azor, used to treat high blood pressure, caused sprue-like enteropathy including severe diarrhea, weight loss and malnutrition.
If you or a family member has used Azor and have been injured, you may be entitled to compensation.
YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY
- Our firm is vigorously pursuing this matter.
- Our clients have received millions of dollars in lawsuits involving defective drugs.
- No Charge or Obligation for Our Experienced Attorney Review
CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.
Azor (olmesartan/amlopidine) is a combination of the drugs Benicar and Norvasc and is used to treat high blood pressure. Azor is manufactured by Daiichi Sankyo, Inc. and was approved by the FDA in 2007 for the treatment of high blood pressure. In 2013, the FDA issued a warning that Azor, and other drugs that contain olmesartan, may increase the risk of sprue-like enteropathy.
In 2014, a complaint was filed against Daiichi Sankyo, Inc. in the United States District Court for the Eastern District of Louisiana. The plaintiff alleges Azor caused him to develop sprue-like enteropathy which included severe diarrhea with substantial weight loss and malnutrition. Plaintiff claims the company failed to adequately research the possible side effects of Azor or warn the public of the risks associated with the drug.